ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial
Glioblastoma multiforme (GBM) carries dismal prognosis and cannot be eradicated surgically because of its wide brain invasion. The objective of this prospective randomised controlled trial was to evaluate ALA and Photofrin® fluorescence-guided resection (FGR) and repetitive photodynamic therapy (PDT) in GBM. We recruited 27 patients; 13 were in the study group and 14 were in the control group. The mean survival of the study group was 52.8 weeks compared to 24.6 weeks in the control group (p < 0.01). The study group gained on average 20 points on the Karnofsky performance score (p < 0.05). There were no differences in complications or hospital stay between the two groups. The mean time to tumour progression was 8.6 months in the study group compared to 4.8 months in the control group (p < 0.05). Therefore, ALA and Photofrin® fluorescence-guided resection and repetitive PDT offered a worthwhile survival advantage without added risk to patients with GBM. A multicentre randomized controlled trial is warranted to confirm these results.
KeywordsLaser Glioblastoma Photodiagnosis Photoirradiation Spectroscopy Surgery
We are grateful to the Laser technicians, nurses, other therapists and doctors, who assisted in delivering care and therapy to our patients.
This study was funded by Barbara Stewart Cancer Trust, a charitable organisation dedicated for funding the advancement of photodynamic techniques in cancer treatment.
- 7.Origitano TC, Karesh SM, Henkin RE, Halama JR, Reichman OH (1993) Photodynamic therapy for intracranial neoplasms: investigations of photosensitizer uptake and distribution using indium-111 photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery 32:357–364PubMedGoogle Scholar
- 13.Eljamel MS (2003) New light on the brain; the role of photosensitizing agents and laser light in the management of malignant brain tumors. Tech Can Res Tr 2:303–309Google Scholar
- 16.Kaye AH, Morstyn G, Brownbill D (1997) Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma, a phase 1–2 study. J Neurosurg 67:500–505Google Scholar
- 21.Muller PJ, Wilson BC (1996) Photodynamic therapy. Neuroncol 11:249–256Google Scholar
- 22.Muller PJ, Wilson BC (1996) Photodynamic therapy for newly diagnosed supratentorial gliomas. J Clin Lasers Med Surg 14:263–270Google Scholar
- 25.Muller PJ, Wilson BC (1985) Photodynamic therapy; cavitary photoillumination of malignant cerebral tumours using a laser coupled inflatable balloon. Can J Neurol Sciences 12:371–373Google Scholar